Substituted imidazo[1,5-a]pyrazines as Btk inhibitors
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, Formula (I) or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.
Merck Sharp & Dohme Corp.
A A A A A A A A A A A A A A A A A A A A A C
A61P A61P A61P A61P A61P A61K A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61K A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Xiaolei Dahai Deodial Guy Shilan Jian Joseph A.
Gao Wang Guiadeen Liu Liu Kozlowski